Back to search results

Study of Enhanced Courage to Quit for Nicotine Use Disorder

This study is testing an improved version of a smoking cessation program called "Enhanced Courage to Quit." It aims to see how well this program can be put into practice at community behavioral health clinics. You might be able to join if you are between 18 and 26 years old, smoke at least one cigarette daily, and are interested in quitting. The study will measure how many people attend the program, how many complete at least four sessions, and how satisfied participants are with the treatment. The study is currently unclear on its recruitment status.

Study design
This is an interventional study with a planned enrollment of 24 participants. It is not specified if it is randomized or blinded.
What's involved
Participants will engage in a group program over a period of 3 months, learning behavioral and cognitive skills for smoking cessation.
Compensation
Not stated in the trial record.
Follow-up
Acceptability will be assessed at the end of treatment (e.g., 3 months or fourth session attended, whichever comes first).

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06837220

Implementation of Tobacco Cessation Programming at Community Behavioral Health Sites

Recruiting
NAAges 18–26InterventionalTreatment
University of Chicago
~24 participants
Updated 2026-07-07 on ClinicalTrials.gov
What's tested:Enhanced Courage to Quit

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of participants who attend the enhanced intervention as assessed by enrollment and sign-in at each session
Measured over 3 months
+2 more outcomes measured

Conditions

Nicotine Use Disorder
Smoking Cessation
Smoking Cessation Intervention

Explore related trials

Nicotine use disorder

Where it's being run

1 sites across 1 states
Illinois1

Who to contact

Emma Brett, PhD
[email protected]
773-834-5341
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Identify as someone who currently smokes combustible cigarettes (at least 1 cigarette per day) on each day for the past month
Report interest in quitting cigarettes (at least 6/10 scale in interest of quitting)
Age 18 or older, ability to understand the English language, willing and able to provide informed consent
Stable residence and contact information throughout the follow up period

Exclusion

Non-daily or intermittent cigarette use
No interest in quitting smoking
Unstable residence/not staying in Chicago for duration of study period
Current untreated severe substance use disorder (with the exception of tobacco use) or past-year serious untreated psychiatric illness (e.g. schizophrenia, bipolar disorder, obsessive compulsive disorder, unspecified psychosis, past-year suicide attempt)

What this trial measures

  • Number of participants who attend the enhanced intervention as assessed by enrollment and sign-in at each session3 months

    Investigators will consider the initial pilot period of the enhanced intervention successful if the team enrolls (attend one session) and retains (attend four or more sessions) at least three participants in the pilot treatment across three months

  • Feasibility will be assessed by calculating the portion of people who enroll (attend at least on session) and complete 4+ sessions versus those who drop out before finishing 4 sessions as assessed by session sign-in3 months

    Investigators will consider the intervention design to be feasible if fewer than 40% of enrollees drop out after their first attended session.

  • A modified version of the Client Satisfaction Questionnaire (CSQ) will assess intervention acceptability.End of treatment (e.g., 3 months or fourth session attended, whichever comes first)

    This measure is a 10-point Likert scale (0=not at all, 10=very much) that assesses items such as intervention quality, effectiveness, and intrusiveness. For acceptability, the study team predicts at least 75% of participants will rate the intervention as acceptable via post-treatment survey (CSQ).